Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury

Basic Research in Cardiology

Volumn 107, Issue 2, 2012, Pages

  Guo, Yiru ^a   Sanganalmath, Santosh K ^a   Wu, Wenjian ^a   Zhu, Xiaoping ^a   Huang, Yiming ^b   Tan, Wei ^a   Ildstad, Suzanne T ^b   Li, Qianhong ^a   Bolli, Roberto ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Chimeric mice; Inducible nitric oxide synthase; Infarct size; Myocardial infarction

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL; BONE MARROW TRANSPLANTATION; CELL PROTECTION; CONTROLLED STUDY; GENE DELETION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART PROTECTION; IRRADIATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; REPERFUSION INJURY; WILD TYPE; ANIMAL; BONE MARROW CELL; C57BL MOUSE; ENZYMOLOGY; HEMATOPOIETIC STEM CELL; HISTOCOMPATIBILITY; METABOLISM; MOUSE MUTANT;

ANIMALS; BLOOD CELLS; BONE MARROW CELLS; HEMATOPOIETIC STEM CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE SYNTHASE TYPE II; TRANSPLANTATION CHIMERA;

EID: 84857029526     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-012-0253-9     Document Type: Article

References (56)

1. Abu-Soud HM, Hazen SL (2000) Nitric oxide modulates the catalytic activity of myeloperoxidase. J Biol Chem 275:5425-5430 (Pubitemid 30115174)
2. Baker CS, Dutka DP, Pagano D, Rimoldi O, Pitt M, Hall RJ, Polak JM, Bonser RS, Camici PG (2002) Immunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium.Basic ResCardiol 97:409-415. doi:10.1007/s0039502 00050
3. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624
4. Bogdan C (2001) Nitric oxide and the immune response. Nat Immunol 2:907-916. doi:10.1038/ni1001-907 (Pubitemid 32976162)
5. Bolli R (2001) Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33:1897-1918. doi:10.1006/jmcc.2001.1462 (Pubitemid 33097270)
6. Bolli R (2000) The late phase of preconditioning. Circ Res 87:972-983
7. Bolli R, Becker L, Gross G, Mentzer R Jr, Balshaw D, Lathrop DA (2004) Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 95:125-134. doi: 10.1161/01.RES.0000137171.97172.d7 (Pubitemid 38988678)
8. Bolli R, Bhatti ZA, Tang XL, Qiu Y, Zhang Q, Guo Y, Jadoon AK (1997) Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 81:42-52 (Pubitemid 27272981)
9. Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, Zhang J (1998) The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93:325-338 (Pubitemid 28499453)
10. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y, Zhang Q, Jadoon AK (1997) The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res 81:1094-1107 (Pubitemid 27514960)
11. Das A, Xi L, Kukreja RC (2005) Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 280:12944-12955. doi:10.1074/jbc.M404706200
12. Feng Q, Lu X, Jones DL, Shen J, Arnold JM (2001) Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 104:700-704 (Pubitemid 32738526)
13. Gealekman O, Abassi Z, Rubinstein I, Winaver J, Binah O (2002) Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation 105:236-243 (Pubitemid 34084325)
14. Gross GJ, Fryer RM (2000) Mitochondrial K(ATP) channels: triggers or distal effectors of ischemic or pharmacological preconditioning? Circ Res 87:431-433
15. Grover GJ, Garlid KD (2000) ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 32:677-695. doi:10.1006/jmcc.2000.1111 (Pubitemid 30658936)
16. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, Han H, Laubach VE, Ping P, Yang Z, Qiu Y, Bolli R (1999) The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 96:11507-11512 (Pubitemid 29487411)
17. Guo Y, Stein AB, Wu WJ, Zhu X, Tan W, Li Q, Bolli R (2005) Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS. Am J Physiol Heart Circ Physiol 289:H2251-H2257. doi:10.1152/ajpheart.00341.2005 (Pubitemid 41507380)
18. Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z, Bolli R (1998) Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol 275:H1375-H1387
19. Hataishi R, Rodrigues AC, Morgan JG, Ichinose F, Derumeaux G, Bloch KD, Picard MH, Scherrer-Crosbie M (2006) Nitric oxide synthase 2 and pressure-overload-induced left ventricular remodelling in mice. Exp Physiol 91:633-639. doi:10.1113/ expphysiol.2005.033068
20. Heger J, Godecke A, Flogel U, Merx MW, Molojavyi A, Kuhn- Velten WN, Schrader J (2002) Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circ Res 90:93-99 (Pubitemid 34074614)
21. Hendgen-Cotta UB, Merx MW, Shiva S, Schmitz J, Becher S, Klare JP, Steinhoff HJ, Goedecke A, Schrader J, Gladwin MT, Kelm M, Rassaf T (2008) Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemiareperfusion injury. Proc Natl Acad Sci USA 105:10256-10261. doi:10.1073/pnas.0801336105
22. Heusch G, Boengler K, Schulz R (2008) Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 118:1915-1919. doi:10.1161/CIRCULATIONAHA.108.805242
23. Heusch G, Post H, Michel MC, Kelm M, Schulz R (2000) Endogenous nitric oxide and myocardial adaptation to ischemia. Circ Res 87:146-152 (Pubitemid 30616911)
24. Ignarro LJ (1991) Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 41:485-490
25. Ischiropoulos H, Zhu L, Beckman JS (1992) Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 298:446-451
26. Jones SP, Greer JJ, Ware PD, Yang J, Walsh K, Lefer DJ (2005) Deficiency of iNOS does not attenuate severe congestive heart failure in mice. Am J Physiol Heart Circ Physiol 288:H365-H370. doi:10.1152/ajpheart.00245.2004 (Pubitemid 40023868)
27. Kolios G, Valatas V, Ward SG (2004) Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 113:427-437. doi:10.1111/j.1365-2567.2004. 01984.x (Pubitemid 39593361)
28. Li H, Colson YL, Ildstad ST (1995) Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts. Transplantation 60:523-529
29. Li H, Kaufman CL, Ildstad ST (1995) Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice. Surgery 118:192-197 (discussion 197- 198)
30. Li Q, Guo Y, Ou Q, Cui C, Wu WJ, Tan W, Zhu X, Lanceta LB, Sanganalmath SK, Dawn B, Shinmura K, Rokosh GD, Wang S, Bolli R (2009) Gene transfer of inducible nitric oxide synthase affords cardioprotection by upregulating heme oxygenase-1 via a nuclear factor-{kappa}B-dependent pathway. Circulation 120:1222-1230. doi:10.1161/CIRCULATIONAHA.108.778688
31. Li Q, GuoY, Tan W, Ou Q,WuWJ, Sturza D, Dawn B, Hunt G, Cui C, Bolli R (2007) Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway. Circulation 116: 1577-1584. doi:10.1161/CIRCULATIONAHA.107.689810 (Pubitemid 47511421)
32. Li Q, Guo Y, Tan W, Stein AB, Dawn B,Wu WJ, Zhu X, Lu X, Xu X, Siddiqui T, Tiwari S, Bolli R (2006) Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences. Am J Physiol Heart Circ Physiol 290:H584-H589. doi:10.1152/ajpheart.00855.2005
33. Li Q, Guo Y, Wu WJ, Ou Q, Zhu X, Tan W, Yuan F, Chen N, Dawn B, Luo L, O'Brien E, Bolli R (2011) Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol 106:1355-1366. doi:10.1007/s00395-011-0207-7
34. Li Q, Guo Y, Xuan YT, Lowenstein CJ, Stevenson SC, Prabhu SD, Wu WJ, Zhu Y, Bolli R (2003) Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism. Circ Res 92:741-748. doi:10.1161/01.RES.0000065441.72685.29 (Pubitemid 36457638)
35. Liu YH, Carretero OA, Cingolani OH, Liao TD, Sun Y, Xu J, Li LY, Pagano PJ, Yang JJ, Yang XP (2005) Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction. Am J Physiol Heart Circ Physiol 289:H2616-H2623. doi:10.1152/ajpheart.00546. 2005 (Pubitemid 41698578)
36. Loke KE, McConnell PI, Tuzman JM, Shesely EG, Smith CJ, Stackpole CJ, Thompson CI, Kaley G, Wolin MS, Hintze TH (1999) Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. Circ Res 84:840-845 (Pubitemid 29181491)
37. MacMicking J, Xie QW, Nathan C (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350. doi:10.1146/ annurev.immunol.15.1.323 (Pubitemid 27169284)
38. Marfella R, Di Filippo C, Esposito K, Nappo F, Piegari E, Cuzzocrea S, Berrino L, Rossi F, Giugliano D, D'Amico M (2004) Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocininduced hyperglycemic mice. Diabetes 53:454-462 (Pubitemid 38174563)
39. Martin C, Schulz R, Post H, Boengler K, Kelm M, Kleinbongard P, Gres P, Skyschally A, Konietzka I, HeuschG(2007) Microdialysisbased analysis of interstitial NO in situ: NO synthase-independent NO formation during myocardial ischemia. Cardiovasc Res 74:46-55. doi:10.1016/j.cardiores.2006.12.020 (Pubitemid 46366945)
40. Mohr S, Hallak H, de Boitte A, Lapetina EG, Brune B (1999) Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde- 3-phosphate dehydrogenase. J Biol Chem 274:9427-9430
41. Pain T, Yang XM, Critz SD, Yue Y, Nakano A, Liu GS, Heusch G, Cohen MV, Downey JM (2000) Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 87:460-466
42. Post H, Schulz R, Behrends M, Gres P, Umschlag C, Heusch G (2000) No involvement of endogenous nitric oxide in classical ischemic preconditioning in swine. J Mol Cell Cardiol 32:725-733. doi:10.1006/jmcc.2000.1117 (Pubitemid 30658910)
43. Pryor WA, Squadrito GL (1995) The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 268:L699-L722
44. Qiu Y, Rizvi A, Tang XL, Manchikalapudi S, Takano H, Jadoon AK, Wu WJ, Bolli R (1997) Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol 273:H2931-H2936
45. Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266:4244-4250 (Pubitemid 21909347)
46. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA (1994) Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 269:26066-26075
47. Sam F, Sawyer DB, Xie Z, Chang DL, Ngoy S, Brenner DA, Siwik DA, Singh K, Apstein CS, Colucci WS (2001) Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Circ Res 89:351-356 (Pubitemid 34132674)
48. Sasaki N, Sato T, Ohler A, O'Rourke B, Marban E (2000) Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 101:439-445 (Pubitemid 30067402)
49. Shinmura K, Xuan YT, Tang XL, Kodani E, Han H, Zhu Y, Bolli R (2002) Inducible nitric oxide synthase modulates cyclooxygenase- 2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res 90:602-608 (Pubitemid 34640911)
50. Szelid Z, Pokreisz P, Liu X, Vermeersch P, Marsboom G, Gillijns H, Pellens M, Verbeken E, Van de Werf F, Collen D, Janssens SP (2010) Cardioselective nitric oxide synthase 3 gene transfer protects against myocardial reperfusion injury. Basic Res Cardiol 105:169-179. doi:10.1007/s00395-009-0077-4
51. Takano H, Bolli R, Black RG Jr, Kodani E, Tang XL, Yang Z, Bhattacharya S, Auchampach JA (2001) A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res 88:520-528 (Pubitemid 32240916)
52. Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, Bolli R (1998) Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 98:441-449 (Pubitemid 28357947)
53. Takano H, Tang XL, Qiu Y, Guo Y, French BA, Bolli R (1998) Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant- sensitive mechanism. Circ Res 83:73-84 (Pubitemid 28322101)
54. Vegh A, Papp JG, Szekeres L, Parratt JR (1993) Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs. Br J Pharmacol 110:18-19 (Pubitemid 23257751)
55. West MB, Rokosh G, Obal D, Velayutham M, Xuan YT, Hill BG, Keith RJ, Schrader J, Guo Y, Conklin DJ, Prabhu SD, Zweier JL, Bolli R, Bhatnagar A (2008) Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition. Circulation 118:1970-1978. doi:10.1161/CIRCULATIONAHA. 108.791533
56. Ziolo MT, Maier LS, Piacentino V 3rd, Bossuyt J, Houser SR, Bers DM (2004) Myocyte nitric oxide synthase 2 contributes to blunted beta-adrenergic response in failing human hearts by decreasing Ca2+ transients. Circulation 109:1886-1891. doi: 10.1161/01.CIR.0000124231.98250.A8 (Pubitemid 38509124)